We are live on
!
Find out more
CAM
Congress Asset Management Portfolio holdings
AUM
$16.3B
1-Year Est. Return
42.69%
This Fund
S&P 500
This Quarter
Est. Return
+9.74%
1 Year Est. Return
+42.69%
3 Year Est. Return
+133.81%
5 Year Est. Return
+171.24%
10 Year Est. Return
+841.07%
AUM
$11.5B
AUM Growth
+$780M
(+7.3%)
Cap. Flow
-$39.7M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
16.02%
Holding
391
New
23
Increased
185
Reduced
140
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Factset
FDS
|
+$106M |
| 2 |
Bruker
BRKR
|
+$98.1M |
| 3 |
HOLX
Hologic
HOLX
|
+$97.4M |
| 4 |
Martin Marietta Materials
MLM
|
+$69M |
| 5 |
Moody's
MCO
|
+$58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Masco
MAS
|
+$103M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$89.3M |
| 3 |
Trimble
TRMB
|
+$81.1M |
| 4 |
Dover
DOV
|
+$79M |
| 5 |
Ciena
CIEN
|
+$60.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.8% |
| 2 | Healthcare | 17.55% |
| 3 | Consumer Discretionary | 15.17% |
| 4 | Industrials | 15.09% |
| 5 | Consumer Staples | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
326
Neurocrine Biosciences
NBIX
$16.6B
| $544K | ﹤0.01% |
5,772
-914,281
| -99% | -$89.3M |
|
327
Vertex Pharmaceuticals
VRTX
$123B
| $535K | ﹤0.01% |
1,519
| – | – |
|
328
iShares Core Conservative Allocation ETF
AOK
$797M
| $534K | ﹤0.01% |
15,157
-38,985
| -72% | -$1.36M |
|
329
SLB Ltd
SLB
$74.6B
| $521K | ﹤0.01% |
10,600
| – | – |
|
330
Shoals Technologies Group
SHLS
$1.5B
| $489K | ﹤0.01% |
+19,126
| New | +$442K |
|
|
ATVI
331
DELISTED
Activision Blizzard
ATVI
| $482K | ﹤0.01% |
5,715
| – | – |
|
332
Vanguard Morningstar Growth ETF
VUG
$231B
| $462K | ﹤0.01% |
9,792
-114
| -1% | -$4.94K |
|
333
Etsy
ETSY
$8.12B
| $441K | ﹤0.01% |
5,216
-261
| -5% | -$24.6K |
|
334
Danaher
DHR
$140B
| $438K | ﹤0.01% |
2,059
| – | – |
|
335
FuelCell Energy
FCEL
$1.75B
| $434K | ﹤0.01% |
6,703
+87
| +1% | +$5.91K |
|
336
Meta Platforms (Facebook)
META
$1.51T
| $429K | ﹤0.01% |
1,494
| – | – |
|
337
Southern Company
SO
$106B
| $423K | ﹤0.01% |
6,015
-250
| -4% | -$17.9K |
|
338
Teradyne
TER
$60.7B
| $417K | ﹤0.01% |
3,750
| – | – |
|
339
Simpson Manufacturing
SSD
$8.14B
| $416K | ﹤0.01% |
3,001
-197,311
| -99% | -$24.3M |
|
340
LendingTree
TREE
$475M
| $415K | ﹤0.01% |
18,767
+200
| +1% | +$4.26K |
|
341
Vail Resorts
MTN
$5.4B
| $413K | ﹤0.01% |
1,640
-670
| -29% | -$163K |
|
342
Canadian National Railway
CNI
$76.6B
| $401K | ﹤0.01% |
3,314
-815
| -20% | -$96.6K |
|
343
Cognex
CGNX
$11.8B
| $395K | ﹤0.01% |
7,043
| – | – |
|
344
Equity Lifestyle Properties
ELS
$12.6B
| $379K | ﹤0.01% |
5,660
-7,753
| -58% | -$516K |
|
345
Corteva
CTVA
$53.3B
| $378K | ﹤0.01% |
6,600
-25
| -0.4% | -$1.46K |
|
346
VeriSign
VRSN
$27B
| $373K | ﹤0.01% |
1,651
+238
| +17% | +$52.5K |
|
|
SEE
347
DELISTED
Sealed Air
SEE
| $354K | ﹤0.01% |
8,838
+185
| +2% | +$7.87K |
|
348
Pfizer
PFE
$146B
| $346K | ﹤0.01% |
9,434
-89
| -0.9% | -$3.46K |
|
349
Generac Holdings
GNRC
$13.2B
| $318K | ﹤0.01% |
2,131
-1,043
| -33% | -$119K |
|
350
Vanguard Morningstar Mid-Cap ETF
VO
$109B
| $314K | ﹤0.01% |
5,712
| – | – |
|
Similar funds
UCFA
LCOV
CCMG
IG
EIP
CI
AIMCA
Congress Asset Management's Q2 2023 Portfolio in Review
As of Q2 2023, Congress Asset Management held 391 positions worth $11.5B, up 7.3% from $10.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Congress Asset Management's Q2 2023 filing shows 23 new, 185 increased, 140 reduced and 18 closed positions. Its largest new stake was Factset: 263,630 shares worth $106M. The largest sale was Masco, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Congress Asset Management's largest Q2 2023 buy was Factset: 263,630 shares worth $106M.
- Congress Asset Management added most to Martin Marietta Materials in Q2 2023, an estimated $69M increase.
- Congress Asset Management's biggest Q2 2023 reduction was Neurocrine Biosciences, cutting an estimated $89.3M.
- Congress Asset Management fully exited Masco in Q2 2023, selling an estimated $103M.
- Congress Asset Management's ten largest holdings make up 16% of its $11.5B portfolio in Q2 2023.
- Congress Asset Management opened 23 new positions and closed 18 in Q2 2023.
- Congress Asset Management's portfolio value rose 7.3% quarter-over-quarter to $11.5B.
Based on Congress Asset Management's 13F filing for Q2 2023, filed 27 Jul 2023.